Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL
NCT04883749
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class
Conditions
Chronic Lymphoid Leukemia
Interventions
BIOLOGICAL:
Acalabrutinib
Sponsor
German CLL Study Group